Literature DB >> 35041116

Volumetric changes within hippocampal subfields in Alzheimer's disease continuum.

Emre Hari1,2,3, Elif Kurt4,5, Ali Bayram4,5, Gozde Kizilates-Evin4,5, Burak Acar6, Tamer Demiralp4,7, Hakan Gurvit4,8.   

Abstract

Neurodegeneration in Alzheimer's disease continuum (ADC) starts from the transentorhinal cortex and progresses within hippocampal circuitry following the connectivity of its subfields transsynaptically. We aimed to track volumetric changes of the hippocampal subfields by comparing three stages of the ADC. MRI data of 15 patients diagnosed with Alzheimer's disease dementia (ADD), 15 patients with amnestic mild cognitive impairment (MCI), and 15 individuals with subjective cognitive impairment (SCI) were analyzed. The hippocampal formation was subdivided into CA1, CA3, subiculum (SUB), and dentate gyrus (DG) using FreeSurfer and volumetric values were obtained. The volumetric values were analyzed with ANCOVA and intracranial volume was selected as a covariate. ANCOVA results of the hippocampal subfields displayed statistically significant differences among the three groups in bilateral CA1, SUB, and DG volumes (Right CA1: F = 7.316, p = 0.002; left CA1: F = 6.768, p = 0.003; right SUB: F = 9.390, p < 0.001; left SUB: F = 5.925, p = 0.005; right DG: F = 9.469, p < 0.001; left DG: F = 9.354, p < 0.001), while CA3 volumes were not significantly different among the groups. Post hoc comparisons revealed that volume reductions in bilateral CA1, DG, and SUB were present in ADD compared to both MCI and SCI groups. No significant volumetric changes were found between the SCI and MCI groups. While our results are generally consistent with the literature in terms of the CA1 and SUB findings, they additionally point to the importance of the significant volume loss in DG and the resilience of the CA3 sector.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Alzheimer’s disease; Hippocampal formation; Hippocampal subfields; Magnetic resonance imaging; Subjective cognitive impairment; Volumetry

Mesh:

Year:  2022        PMID: 35041116     DOI: 10.1007/s10072-022-05890-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  34 in total

1.  Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; S C Waring; P C O'Brien; E G Tangalos; G E Smith; R J Ivnik; E Kokmen
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

Review 2.  Molecular Pathogenesis of Alzheimer's Disease: An Update.

Authors:  Alfredo Sanabria-Castro; Ileana Alvarado-Echeverría; Cecilia Monge-Bonilla
Journal:  Ann Neurosci       Date:  2017-04-21

3.  Implementation of subjective cognitive decline criteria in research studies.

Authors:  José L Molinuevo; Laura A Rabin; Rebecca Amariglio; Rachel Buckley; Bruno Dubois; Kathryn A Ellis; Michael Ewers; Harald Hampel; Stefan Klöppel; Lorena Rami; Barry Reisberg; Andrew J Saykin; Sietske Sikkes; Colette M Smart; Beth E Snitz; Reisa Sperling; Wiesje M van der Flier; Michael Wagner; Frank Jessen
Journal:  Alzheimers Dement       Date:  2016-11-05       Impact factor: 21.566

4.  AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.

Authors:  Frank Jessen; Steffen Wolfsgruber; Birgitt Wiese; Horst Bickel; Edelgard Mösch; Hanna Kaduszkiewicz; Michael Pentzek; Steffi G Riedel-Heller; Tobias Luck; Angela Fuchs; Siegfried Weyerer; Jochen Werle; Hendrik van den Bussche; Martin Scherer; Wolfgang Maier; Michael Wagner
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

5.  MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.

Authors:  C R Jack; R C Petersen; P C O'Brien; E G Tangalos
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

6.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Authors:  P Scheltens; D Leys; F Barkhof; D Huglo; H C Weinstein; P Vermersch; M Kuiper; M Steinling; E C Wolters; J Valk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 7.  The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease.

Authors:  Barry Reisberg; Leslie Prichep; Lisa Mosconi; E Roy John; Lidia Glodzik-Sobanska; Istvan Boksay; Isabel Monteiro; Carol Torossian; Alok Vedvyas; Nauman Ashraf; Imran A Jamil; Mony J de Leon
Journal:  Alzheimers Dement       Date:  2008-01       Impact factor: 21.566

8.  White-matter changes in early and late stages of mild cognitive impairment.

Authors:  Banu Femir-Gurtuna; Elif Kurt; Cigdem Ulasoglu-Yildiz; Ali Bayram; Elif Yildirim; Ezgi Soncu-Buyukiscan; Basar Bilgic
Journal:  J Clin Neurosci       Date:  2020-04-22       Impact factor: 1.961

9.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

Review 10.  The neuropathological diagnosis of Alzheimer's disease.

Authors:  Michael A DeTure; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2019-08-02       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.